The creatine kinase system and pleiotropic effects of creatine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1007\/s00726-011-0877-3<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-011-0877-3.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1186\/s12970-017-0173-z<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC5469049?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1155\/2012\/960363<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC3263635?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1007\/s00726-020-02823-6<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-020-02823-6.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.1212\/01.wnl.0000201252.57661.e1<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Creatine: endogenous metabolite, dietary, and therapeutic supplement.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2007<\/year><\/dates><electronic-resource-num>10.1146\/annurev.nutr.27.061406.093621<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1971<\/year><\/dates><electronic-resource-num>10.1172\/jci106762<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.jci.org\/articles\/view\/106762\/files\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2000<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.20-12-04389.2000<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/20\/12\/4389.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1998<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.18-01-00156.1998<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/18\/1\/156.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2001<\/year><\/dates><electronic-resource-num>10.1086\/320595<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.cell.com\/article\/S000292970761060X\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>ATP flux through creatine kinase in the normal, stressed, and failing human heart.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1073\/pnas.0408962102<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/545546<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1016\/j.cell.2015.09.035<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.cell.com\/article\/S0092867415011976\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Statin-associated myopathy with normal creatine kinase levels.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.7326\/0003-4819-137-7-200210010-00009<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Creatine deficiency in the brain: a new, treatable inborn error of metabolism.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1994<\/year><\/dates><electronic-resource-num>10.1203\/00006450-199409000-00023<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1996<\/year><\/dates><electronic-resource-num>10.1161\/01.cir.94.7.1528<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Theo Vos<\/author><author>Ryan M Barber<\/author><author>Brad Bell et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(15)60692-4<\/electronic-resource-num><urls><related-urls><url>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4561509\/pdf\/emss-64121.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Yao Li<\/author><author>Jiaying Yao<\/author><author>Chunyan Han et al.<\/author><\/authors><\/contributors><titles><title>Quercetin, Inflammation and Immunity<\/title><secondary-title>Nutrients<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.3390\/nu8030167<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2072-6643\/8\/3\/167\/pdf?version=1458035001<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Andrew K. Davis<\/author><author>Donna L. Maney<\/author><author>John C. Maerz<\/author><\/authors><\/contributors><titles><title>The use of leukocyte profiles to measure stress in vertebrates: a review for ecologists<\/title><secondary-title>Functional Ecology<\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1111\/j.1365-2435.2008.01467.x<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/j.1365-2435.2008.01467.x<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Stephen V. Faraone<\/author><author>Henrik Larsson<\/author><\/authors><\/contributors><titles><title>Genetics of attention deficit hyperactivity disorder<\/title><secondary-title>Molecular Psychiatry<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1038\/s41380-018-0070-0<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41380-018-0070-0.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Susan H. Fox<\/author><author>Regina Katzenschlager<\/author><author>Shen\u2010Yang Lim et al.<\/author><\/authors><\/contributors><titles><title>International Parkinson and movement disorder society evidence\u2010based medicine review: Update on treatments for the motor symptoms of Parkinson's disease<\/title><secondary-title>Movement Disorders<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1002\/mds.27372<\/electronic-resource-num><urls><related-urls><url>https:\/\/pure.amsterdamumc.nl\/ws\/files\/158527287\/International-parkinson-and-movement-disorder-society-evidence-based-medicine-review-update-on-treatments-for-the-motor.pdf<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type><\/authors><\/contributors>The creatine kinase system and pleiotropic effects of creatine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1007\/s00726-011-0877-3<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-011-0877-3.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1186\/s12970-017-0173-z<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC5469049?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1155\/2012\/960363<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC3263635?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1007\/s00726-020-02823-6<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-020-02823-6.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><electronic-resource-num>10.1212\/01.wnl.0000201252.57661.e1<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Creatine: endogenous metabolite, dietary, and therapeutic supplement.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2007<\/year><\/dates><electronic-resource-num>10.1146\/annurev.nutr.27.061406.093621<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1971<\/year><\/dates><electronic-resource-num>10.1172\/jci106762<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.jci.org\/articles\/view\/106762\/files\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2000<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.20-12-04389.2000<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/20\/12\/4389.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1998<\/year><\/dates><electronic-resource-num>10.1523\/jneurosci.18-01-00156.1998<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.jneurosci.org\/content\/jneuro\/18\/1\/156.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2001<\/year><\/dates><electronic-resource-num>10.1086\/320595<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.cell.com\/article\/S000292970761060X\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>ATP flux through creatine kinase in the normal, stressed, and failing human heart.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2005<\/year><\/dates><electronic-resource-num>10.1073\/pnas.0408962102<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/545546<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1016\/j.cell.2015.09.035<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.cell.com\/article\/S0092867415011976\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Statin-associated myopathy with normal creatine kinase levels.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><electronic-resource-num>10.7326\/0003-4819-137-7-200210010-00009<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Creatine deficiency in the brain: a new, treatable inborn error of metabolism.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1994<\/year><\/dates><electronic-resource-num>10.1203\/00006450-199409000-00023<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>1996<\/year><\/dates><electronic-resource-num>10.1161\/01.cir.94.7.1528<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Theo Vos<\/author><author>Ryan M Barber<\/author><author>Brad Bell et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(15)60692-4<\/electronic-resource-num><urls><related-urls><url>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4561509\/pdf\/emss-64121.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Yao Li<\/author><author>Jiaying Yao<\/author><author>Chunyan Han et al.<\/author><\/authors><\/contributors><titles><title>Quercetin, Inflammation and Immunity<\/title><secondary-title>Nutrients<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.3390\/nu8030167<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2072-6643\/8\/3\/167\/pdf?version=1458035001<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Andrew K. Davis<\/author><author>Donna L. Maney<\/author><author>John C. Maerz<\/author><\/authors><\/contributors><titles><title>The use of leukocyte profiles to measure stress in vertebrates: a review for ecologists<\/title><secondary-title>Functional Ecology<\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1111\/j.1365-2435.2008.01467.x<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1111\/j.1365-2435.2008.01467.x<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Stephen V. Faraone<\/author><author>Henrik Larsson<\/author><\/authors><\/contributors><titles><title>Genetics of attention deficit hyperactivity disorder<\/title><secondary-title>Molecular Psychiatry<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1038\/s41380-018-0070-0<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41380-018-0070-0.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Susan H. Fox<\/author><author>Regina Katzenschlager<\/author><author>Shen\u2010Yang Lim et al.<\/author><\/authors><\/contributors><titles><title>International Parkinson and movement disorder society evidence\u2010based medicine review: Update on treatments for the motor symptoms of Parkinson's disease<\/title><secondary-title>Movement Disorders<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1002\/mds.27372<\/electronic-resource-num><urls><related-urls><url>https:\/\/pure.amsterdamumc.nl\/ws\/files\/158527287\/International-parkinson-and-movement-disorder-society-evidence-based-medicine-review-update-on-treatments-for-the-motor.pdf<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"